Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for abrdn Healthcare Investors's Debt-to-Equity or its related term are showing as below:
HQH's Debt-to-Equity is not ranked *
in the Asset Management industry.
Industry Median: 0.22 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
abrdn Healthcare Investors Debt-to-Equity Related Terms
abrdn Healthcare Investors Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, abrdn Healthcare Investors's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Healthcare Investors Debt-to-Equity vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where abrdn Healthcare Investors's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Healthcare Investors (HQH) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on abrdn Healthcare Investors and its competitors. According to the industry distribution chart, abrdn Healthcare Investors ranks #999999 out of 928 companies in the Asset Management industry.
Is abrdn Healthcare Investors' Debt-to-Equity too high?
abrdn Healthcare Investors' current Debt-to-Equity is 0.00. Based on the distribution chart, abrdn Healthcare Investors ranks #999999 out of 928 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' Debt-to-Equity compare to MSDL and HYT?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #999999 out of 928 companies for Debt-to-Equity. This places abrdn Healthcare Investors in the lower half of its industry. The industry median Debt-to-Equity is 0.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Asset Management company?
The median Debt-to-Equity among Asset Management companies is 0.22, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on abrdn Healthcare Investors and its competitors. For the Asset Management industry, the median Debt-to-Equity is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $21.33 — trading 57.6% below its estimated fair value. The current Debt-to-Equity is 0.00. abrdn Healthcare Investors' overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Healthcare Investors (HQH) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued.
The current stock price of $21.33 is trading 57.6% below its estimated GF Value™ of $50.26.
GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.
Key valuation signals for HQH:
Debt-to-Equity: 0.00
GF Value™: $50.26 vs. price of $21.33 (57.6% below fair value)
No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
49GF Score
Get the complete analysis for HQH
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQH has been successfully added to your 
